<DOC>
	<DOCNO>NCT00226616</DOCNO>
	<brief_summary>Cholera one lead cause morbidity mortality among child adult develop country . We evaluate effect supplementation zinc reduction duration severity cholera . Since cholera primarily disease old child adult , intend study effect zinc supplementation among child 3 14 year age , whose initial stool weight &gt; 4ml/kg/hour 1st 6 hour dark field examination positive . 90 subject group hospitalize cholera diarrhea le 24 hour select . After inclusion study , inform consent obtain guardian explain full procedure hospital . The subject randomize receive either zinc placebo diarrhea resolve . History illness baseline information collect hospital interview , may take duration 10 minutes.After 6 hour initial rehydration , fluid balance study carry subject diarrhea resolve . 1 ml ( 1/4 teaspoonful ) blood sample take assess serum zinc level admission initial hydration repeat day recovery . This procedure carry small risk infection do sanitary condition ; however , maintain proper sanitation , risk procedure . There potential risk study.20mg elemental Zinc give daily 2 divided dos till cholera resolve . Both group receive syrup tablet Erythromycin 50mg/kg/24 4 divide dos 3 day . Oral rehydration solution/intravenous acetate fluid use rehydration . Daily body weight take stool send C/S day recovery 5 day . Zinc loss stool see 20 % random stool sample . Information obtain history laboratory investigation subject keep strictly confidential one investigator study Ethics Committee Centre will/ access information . The study benefit patient study physician close observation , examination take care frequently , research staff monitor systematic progress take necessary action . Study micronutrient ( zinc ) show benefit child acute diarrhea . If result study positive , benefit patient treatment study thereafter . The data analyze clinical effect zinc diarrhea.The study help improve treatment strategy cholera child . The study use hospital record , return completion study . Stool , urine 1 ml ( 1/4 teaspoonful ) venous blood take assess serum zinc level .</brief_summary>
	<brief_title>Zinc Supplementation Cholera Patients</brief_title>
	<detailed_description>Study design : A double blind randomize clinical trial use zinc placebo . Randomization : Patients randomize one two group , A B . Block randomization do use block length 6 . Group A receive Zinc+ Erythromycin Group B : receive Placebo+Erythromycin Dose Erythromycin Syrup/tab Erythromycin 50mg/kg/24 hour 4 divide dos 3 day . Dose zinc : Zinc acetate give 10mg twice daily ( 10mgx2=20mg elemental zinc ) cholera resolve ( time passage last unformed stool first form stool follow 24 hour without diarrheal stool ) . Composition syrup : For group , bulk base syrup consist chemical ; addition , group A treatment substance ( i.e . elemental zinc 20 mg/day ) Syrup A : Quantity per 5 ml Zinc Acetate 10 mg elemental zinc Syrup B : Base substance Base Substance : Ascorbic acid 30 mg Glycerin USP 1.2 ml Propylene glycol USP 0.75 ml Sorbitol 70 % BP 2.0 ml Methyl Paraben USFN 3.5 mg Polysorate-80 50 mg ( Tween –80 ) BPC Lemon oil PH grade 0.0125 ml Caramel Brown colour 1 mg Purified water 0.75 ml Clinical procedure hospital : Patients meet selection criterion observe initial six hour , urine stool specimen collect separately . Patient whose initial stool-output &gt; 4ml/kg/hour period dark field examination stool positive enrol study . Patients keep study ward . After complete hydration , patient randomise block 6 one two group A B . Group A receive syrup zinc group B receive placebo till cholera resolve . Both group receive identical bottle contain syrup flavor single unique serial number write bottle . The number indicate exact subject study . Both group receive Syrup/Tab Erythromycin . 1ml blood collect serum zinc admission complete dehydration test repeat time discharge . Stool culture sensitivity ( C/S ) send daily day recovery 5 day . Balance perform patient till cholera resolve . If complication develop enrollment , study discontinue patient treat accordingly . Assessment dehydration : To reduce observational variation , especially regard assessment dehydration , standardized form develop assessment dehydration . CONDITION* ( 1=normal , 2=irritable/lessactive , 3=lethargic/comatose ) MUCOSA ( 1=normal , 2=dry ) EYES ( 1=normal , 2=sunken ) THIRST* ( 1=normal , 2=thirsty , 3=unable drink ) SKIN TURGOR* ( 1=normal , 2=reduced ) PULSE* ( 1=normal , 3=feeble/absent ) DEHYDRATION STATUS : 1. sign dehydration 2. dehydration ( two sign cod 2 least one key sign* ) 3. severe dehydration ( dehydration , plus one key sign* cod 3 ) ( * This method recently validate group international expert oral rehydration therapy invite ICDDR , B currently use large WHO sponsor multi-centre trial evaluation low osmolarity ORS . The investigator train method ) . Rehydration phase : All patient recruit study , either , dehydration severe dehydration . Therefore , randomize study , initial 6 hour patient rehydrated either ORS intravenous fluid . Patients sign dehydration rehydrated ORS patient severe dehydration rehydrated intravenously describe . The following IV fluid use : Sodium Potassium Chloride Acetate Dhaka Solution ( mmol/L ) ( mmol/L ) ( mmol/L ) ( mmol/L ) 133 13 98 48 Rate administration 100 ml/kg 4 hour , plus volume-for-volume replacement ongoing loss hourly . If , end four hour : 1 . The patient fully rehydrated , he/she randomize one treatment group ; 2 . Some dehydration persist , IV infusion continue rate 50 ml /kg 2 hour , plus replacement volume volume ongoing loss ; 3 . Severe dehydration persists , IV infusion continue additional 2 hour rate 100 ml/kg , plus replacement ongoing loss . This unusual , however , occur patient pass large watery stool frequently . If end six hour , patient fully rehydrated patient randomize one treatment group . If sign dehydration persist 6 hour , patient exclude study . All intake output initial rehydration phase record . Maintenance phase : After completion rehydration , subject randomize one two group Group A Group B . Group A give zinc acetate group B give placebo . The supplementation zinc placebo continue till diarrhea resolve . Ongoing stool loss replace equal volume Rice-ORS . Dietary management : Standardize hospital diet give patient include milk suji , rice , vegetable , daal , bread banana chicken fish . Intake output measurement : All oral intravenous fluid measure record cholera resolve . Stool weight measure separately urine every 8 hour cholera resolve . Urine separate measure 8 hourly , weight vomitus also take 8 hourly . Daily clinical examination do investigator study physician observation stool consistency character . Clinical recovery : Clinical recovery define time passage last unformed stool first form stool follow 24 hour without diarrheal stool . Sample size calculation : We assume zinc reduce 20 % mean duration illness compare erythromycin group18 90 % power 5 % level confidence . Therefore sample size : n=2 ( SD ) 2 aß/ ( D ) 2 n=2 ( 5 ) 2 10.5/ ( 2.6 ) 2 n=77.66=78 per treatment group So total number sample 78 x 2 =156 . Considering 15 % drop total number sample 156+24=180 Assessment weight gain : Weight take admission daily cholera resolve . Laboratory test : 1 . Microscopic examination 1 . Dark field examination do stool sample admission . 2 . Microbiological assay : 1 Daily stool C/S do till cholera resolve 5 day . 3 . Micronutrient assay : 1 . Serum zinc level obtain day 1 day recovery 2 . Randomly zinc loss cholera see 20 % sample .</detailed_description>
	<mesh_term>Cholera</mesh_term>
	<mesh_term>Zinc</mesh_term>
	<criteria>Children age 314 year hospitalize ICDDR , B present cholera within 24 hour onset . Stool output 4ml/kg/hour within first 6 hour observation period . Positive dark field examination Unable rehydrate within 6 hour Negative dark field examination Systemic illness require immediate administration antibiotic . Received antibiotic 24 hour prior hospitalization Patients present bloody mucoid diarrhea Unconscious medical emergency</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Zinc</keyword>
	<keyword>cholera</keyword>
	<keyword>child</keyword>
	<keyword>Bangladesh</keyword>
</DOC>